Try our beta test site

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) (RHAPSODY)

This study has been completed.
Information provided by:
Abbott Identifier:
First received: May 23, 2007
Last updated: October 4, 2007
Last verified: October 2007